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Background: The close contact between cats and humans poses a threat to public health because of the potential
zoonotic transmission of influenza viruses to humans. Therefore, we examined the seroprevalence of pandemic
H1N1/09, canine H3N2, and human H3N2 viruses in pet cats in northern China from 2010 to 2014.
Finding: Of 1794 serum samples, the seropositivity rates for H1N1/09, canine H3N2, and human H3N2 were
5.7%, 0.7%, and 0.4%, respectively. The seropositivity rate for H1N1/09 in cats was highest in 2010 (8.3%), and then
declined continuously thereafter. Cats older than 10 years were most commonly seropositive for the H1N1/09 virus.
Conclusions: Our findings emphasize the need for continuous surveillance of influenza viruses in cats in China.
Keywords: Influenza, Antibodies, CatDifferent subtypes of influenza viruses are reported to be
naturally transmitted to cats from other species worldwide,
including avian viruses (H5N1), canine viruses (H3N2),
and human viruses (pandemic H1N1/09, seasonal H1N1,
and H3N2) [1-3]. The close contact between cats and
humans possesses a threat to public health because of the
potential zoonotic transmission of influenza viruses to
humans. In China, the canine H3N2 and H1N1/09 influ-
enza viruses circulate in dogs [4], and the seasonal H3N2
and H1N1/09 viruses are prevalent in humans [5,6], any
of which might be transmitted to cats. Therefore, we ex-
amined the seroprevalence of the pandemic H1N1/09, ca-
nine H3N2, and human seasonal H3N2 influenza viruses
in cats in northern China from January 2010 to June 2014.
A total of 1794 serum samples were collected from do-
mestic cats that presented to the Veterinary Teaching
Hospital of China Agricultural University between January
2010 and June 2014 (average, 33.2 ± 9.7 samples/month).
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canine influenza virus has been described previously [7].
The pandemic A/Beijing/7/2009 (H1N1) and seasonal A/
Beijing/126/2012 (H3N2) viruses were isolated from
patients with influenza-like illnesses. These viruses were
used for both hemagglutination inhibition (HI) and
microneutralization (MN) assays. The serum samples
were treated with receptor-destroying enzyme (RDE; 1
part serum, 3 parts RDE; Denka Seiken, Ltd, Tokyo, Japan)
for 18 h at 37°C, which was then heat inactivated at 56°C
for 30 min. Then, 25 μL of serial two fold dilutions of the
treated serum samples were mixed with 4 HA units of
virus in V-shaped microtiter plates and incubated at room
temperature for 30 min. Next 25 μL of 1% chicken RBCs
was added to each well and incubated at room
temperature for 30 min [8]. The HI titers of tested serum
samples ranged from 0 to 512, and samples with HI anti-
body titers ≥ 32 were considered positive. HI antibody titer
is defined as the reciprocal of the highest serum dilu-
tion that completely inhibits hemagglutination reac-
tion. WHO guidelines for vaccine evaluation suggest that
HI antibody titers 40 indicate 50% protection against in-
fluenza A virus [9,10]. Therefore, we defined HI antibody
titers 32 as the cut-off levels to estimate the infection ratesThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 HI titers in serum samples positive for H1N1/09,
canine H3N2, or human H3N2 virus in cats. In total, 1794 serum
specimens were tested with an HI assay, and HI antibody titers≥ 32
were considered positive. The number of positive serum samples for
each virus is shown. GMTs and 95% confidence intervals are
indicated by long and short horizontal lines, respectively.
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(0.7%), and 8 (0.4%) were positive for H1N1/09, canine
H3N2, and human H3N2 influenza-virus-specific anti-
bodies, respectively. The seropositivity rate for H1N1/09
in cats was highest in 2010 (8.3%), and then declined con-
tinuously thereafter (Figure 1), whereas those for the ca-
nine H3N2 and human H3N2 viruses were relatively low
in each year. The geometric mean titers (GMTs) of the
antibodies against the H1N1/09, canine H3N2, and hu-
man H3N2 viruses were 139.9, 149.3, and 44.0, respect-
ively (Figure 2).
All the serum samples that were HI-positive for H1N1/09,
canine H3N2, or human H3N2 viruses and a negative
control serum sample were tested for each of the three
viruses with an enzyme-linked immunosorbent assay
(ELISA)-based MN assay [13]. Briefly, the treated sera
were serially diluted two fold in duplicate and incubated
with the test virus at a final viral concentration of 100 50%
tissue culture infection dose (TCID50)/100 μL for 2 h at
37°C. The serum–virus mixture was transferred onto an
MDCK cell monolayer maintained in minimum essential
medium supplemented with TPCK trypsin (2 μg/mL;
Worthington Biochemical Corp., USA) and incubated for
24 h. The reaction plate of the MN assay was tested with
an ELISA for the presence of the viral nucleoprotein using
a specific mouse monoclonal antibody (AA5H; 1:1500 di-
lution; Abcam Ltd, Hong Kong) as the primary antibody
and a goat anti-mouse IgGs antibody as the secondary
antibody. The antibody titer was defined as the reciprocal
of the highest serum dilution that reduced the amount
of viral nucleoprotein in the reaction wells by 50%
compared with that in the control wells. The MN titers
for the tested strains in the selected samples were all ≥ 80
(range, 80–1280), which correlated with the HI titers
according to Spearman’s rank correlation (correlation
coefficient = 0.309; P = 0.001), and minimal nonspecific
cross-reactivity (MN titers ≤ 20) was observed among
the subtypes (Figure 3).
The associations between age, sex or seasonality and
the seroprevalence of H1N1/09, canine H3N2, and hu-
man H3N2 in cats were investigated. Pearson’s χ2 testFigure 1 Yearly seroprevalence of influenza viruses in domestic
cats in northern China.was used to compare the differences between groups.
The results are presented in Table 1, and showed that
the seroprevalence of H1N1/09 differed statistically sig-
nificantly among the different age groups (P < 0.001). The
seropositive rate for H1N1/09 was higher in cats aged
more than 10 years than in the other age groups. There
were no statistically significant differences in the sero-
prevalence of either the canine H3N2 (P = 0.876) or hu-
man H3N2 (P = 0.754) virus among the age groups. No
significant differences in the seroprevalence of any virus
tested according to sex or seasonality were observed
(P > 0.05).
Although neither H1N1/09, canine H3N2, nor human
H3N2 has previously been isolated from cats in China,
we provided serological evidence that these viruses in-
fected cats in this country. H1N1/09 influenza virus has
been repeatedly detected in cats in other countries, and
the infected cats present severe respiratory symptoms or
even death [14-16]. Evidence of the cat-to-cat transmis-
sion of H1N1/09 has be observed both experimentally
and clinically [15,17]. In contrast, only one canine H3N2Figure 3 MN titers in serum samples positive for H1N1/09,
canine H3N2, or human H3N2 virus in cats. The controls and
nonspecific cross-reactivity samples (MN titers≤ 20) were included.
Table 1 Characteristics of the tested cats for three influenza viruses and the seroprevalence of the sera against these
influenza viruses
Characteristic No. (%) samplesa No. (%) positive
H1N1/09b Canine H3N2c Human H3N2d
Age (year)
≤2 455 (25.4%) 12 (2.6%) 2 (0.4%) 1 (0.2%)
3-6 463 (25.8%) 13 (2.8%) 4 (0.9%) 3 (0.6%)
7-9 334 (18.6%) 21 (6.3%) 2 (0.6%) 2 (0.6%)
≥10 542 (30.2%) 56 (10.3%) 4 (0.7%) 2 (0.4%)
Pe < 0.001 P = 0.876 P = 0.754
Sex
Male 1028 (57.3%) 53 (5.2%) 5 (0.5%) 4 (0.4%)
Female 766 (42.7%) 49 (6.4%) 7 (0.9%) 4 (0.5%)
P = 0.261 P = 0.272 P = 0.676
Season
Spring (Mar–May) 578 (32.2%) 39 (6.7%) 2 (0.3%) 1 (0.2%)
Summer (Jun–Aug) 352 (19.6%) 15 (4.3%) 3 (0.9%) 1 (0.3%)
Autumn (Sep–Nov) 446 (24.9%) 22 (4.9%) 4 (0.9%) 4 (0.9%)
Winter (Dec–Feb) 418 (23.3%) 26 (6.2%) 3 (0.7%) 2 (0.5%)
P = 0.356 P = 0.694 P = 0.357
aHI positive samples were analyzed. bH1N1/09 is A/Beijing/7/2009 (H1N1). cCanine H3N2 is A/canine/Beijing/359/2009 (H3N2). dHuman H3N2 is A/Beijing/126/
2012 (H3N2). ePearson’s χ2 test was used to compare the differences between groups.
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seasonal H3N2 virus has been detected in cats. Consist-
ent with these data, the seroprevalence of H1N1/09
(5.7%) was higher than that of canine H3N2 (0.7%) or
human seasonal H3N2 (0.4%) in the present study.
Cats aged 10 years or more had a higher seropreva-
lence of H1N1/09 influenza virus than the other age
groups, which might be attributable to the reduced im-
munity of old cats. The seropositivity rate of H1N1/09
influenza in this study (5.7%) was higher than that in do-
mestic cats in Germany in the period from 2010 to 2011
(1.9%) [18], or in cats in southern China (1.2% by ELISA
and 0.6% by HI) [19]. A high prevalence of H1N1/09
was observed among domestic cats in America during
the 2009–2010 influenza season (21.8%) [20], and an
H1N1/09 outbreak, with a seroprevalence (55%), oc-
curred in a cat colony in Italy in November 2009 [15].
Zhao et al. found a particularly high seropositivity rate
for H1N1/09 (21%) in northeastern China from 2012 to
2013 [21]. Our results show that the highest seropositiv-
ity rate in cats during the period examined was in 2010,
which was possibly related to the outbreak of the H1N1/
09 virus in humans in China.
The present study demonstrates that the H1N1/09, ca-
nine H3N2, and human H3N2 influenza viruses are
prevalent in cats in China. Therefore, the continuous
surveillance of influenza viruses in cats in China isnecessary to monitor the threat of infection at the hu-
man–animal interface.
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